Venture Capital Investments

Innate Pharma

Founded in 1999 and financed by leading capital investors until its flotation on the Euronext Paris market in 2006, Innate Pharma S.A. (Euronext Paris - IPH) is a biopharmaceutical company which develops medical treatments that make use of new mechanisms to target the inborn immune system.